Characterization of 19 novel gene mutation sites associated with autosome-dominant polycystic kidney disease
10.3760/cma.j.cn112138-20231228-00412
- VernacularTitle:19个常染色体显性遗传多囊肾新型基因突变位点的特征研究
- Author:
Junlan YANG
1
;
Siqi PENG
;
Zhiyuan WEI
;
Jianan JIANG
;
Bin WANG
;
Fengmei WANG
;
Xiaotong XIE
;
Tian XU
;
Xiaoliang ZHANG
Author Information
1. 东南大学医学院，南京210009
- Keywords:
Polycystic kidney, autosomal dominant;
Polycystic kidney disease;
Gene mutation;
Genetic testing
- From:
Chinese Journal of Internal Medicine
2024;63(9):866-873
- CountryChina
- Language:Chinese
-
Abstract:
By analyzing the of genetic testing data of patients with renal polycystic kidney disease and their relatives, this study aims to identify unreported novel gene mutation sites associated with autosomal dominant polycystic kidney disease (ADPKD). Structural prediction software was employed to investigate protein structural changes before and after mutations, explore genotype-phenotype correlations, and enrich the ADPKD gene database. In this single-center retrospective study, patients with multiple renal cysts diagnosed from January 2019 to February 2023 at the Zhong Da Hospital Southeast University were included. Genetic and clinical data of patients and their families were collected. Unreported novel gene mutation sites associated with ADPKD were identified. The AlphaFold v2.3.1 software was used to predict protein structures. Changes in protein structure before and after mutations were compared to explore genotype-phenotype correlations and enrich the ADPKD gene database. Twelve mutated genes associated with renal cysts were detected in 52 families. Nineteen novel gene mutation sites associated with ADPKD were identified, including 17 mutations in the PKD1 gene (one splicing mutation, seven frameshift mutations, four nonsense mutations, one whole-codon insertion, and four missense mutations); one ALG9 missense mutation; and one chromosomal structural variation. Truncating mutations in the PKD1 gene were correlated with a more severe clinical phenotype, while non-truncating mutations were associated with greater clinical heterogeneity. Numerous novel gene mutation sites associated with ADPKD remain unreported. Therefore, it is essential to analyze the pathogenicity of these novel mutation sites, establish genotype-phenotype correlations, and enrich the ADPKD gene database.
